Mode
Text Size
Log in / Sign up

Protocol for a future systematic review on pediatric limb arteriovenous malformationsPlanned review will study treatments for limb blood vessel tangles in kids

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider this protocol as a plan for future evidence synthesis on pediatric limb arteriovenous malformations.

This document is a protocol for a planned systematic review on peripheral arteriovenous malformations of the limbs in children. The scope is to synthesize evidence on interventions, with a primary outcome of short-term symptom improvement rate within 3 months post-intervention. Secondary outcomes include adverse event incidence and quality of life.

The authors plan to address gaps noted in prior literature, including non-standardized criteria, small-sample uncontrolled studies, and inconsistent efficacy evaluation. No pooled effect sizes or trial-level data are available, as this is a protocol and no data have been collected yet.

Key limitations acknowledged by the authors are the non-standardized criteria, small-sample uncontrolled studies, and inconsistent efficacy evaluation in the existing literature. The review's practice relevance is not reported.

The protocol does not specify a study population sample size, intervention details, or comparator groups. Safety data are not reported, as no trials have been conducted. The authors note that the review will not fabricate trial-level detail, such as sample sizes or effect sizes.

Researchers are planning a review to study treatments for peripheral arteriovenous malformations in the limbs of children. These are rare tangles of blood vessels that can cause pain, swelling, and other problems. The main goal is to see how well different interventions work to improve symptoms within three months.

The review will look at studies where children received any type of treatment for these limb tangles. It will compare these treatments to see which ones help reduce pain and swelling the most. The main thing they will measure is how many kids have better symptoms after three months.

They will also check for safety issues, like bad side effects from the treatments. Another goal is to see how the treatments affect the children's daily life and well-being. The review plans to follow kids for about three months after their treatment.

This plan is important because there are not many good studies on this topic for children. Past research has been small and not well organized. This review could help doctors know which treatments are safest and most helpful for young patients.

What this means for you:
A planned review will find the best treatments for kids with painful limb blood vessel tangles.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BackgroundPeripheral arteriovenous malformations (pAVMs) of the limbs are common in children, with distinct clinical features and high intervention difficulty. Existing research on its interventions is controversial due to non-standardized criteria, small-sample uncontrolled studies and inconsistent efficacy evaluation, leaving clinicians without high-quality evidence-based guidance.Methods and analysisThis study will conduct a PROSPERO-registered systematic review, searching PubMed, Embase and other databases for relevant clinical studies. Two researchers will independently screen literature, extract data and assess evidence quality via GRADE. RevMan 5.4 will be used for qualitative and quantitative statistical analysis, with subgroup and sensitivity analyses to explore heterogeneity. Primary outcome is short-term symptom improvement rate within 3 months post-intervention; secondary outcomes include adverse event incidence and quality of life.Ethics and disseminationEthical approval is not required because this study is a secondary analysis of existing data. We will disseminate the findings through peer-reviewed publications.Clinical Trial RegistrationPROSPERO (CRD420261326988).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.